Integrated
Annual Report 2016

Highlights of the financial year 2016

Net sales


+6.4%
Or­ganic, cur­rency-ad­justed net sales growth in 2016
Net sales de­vel­op­ment
2007 – 2016
(in CHF mil­lion)
EBIT, EBITDA, Net in­come,
Earn­ings per share (EPS)
2014 – 2016
(in CHF mil­lion) (EPS: in CHF)
* Ad­justed for ac­qui­si­tion, di­vest­ment and in­te­gra­tion costs and in­come in con­nec­tion with the San­itec ac­qui­si­tion
Net in­come de­vel­op­ment
2007 – 2016
(in CHF mil­lion)
* Ad­justed for ac­qui­si­tion, di­vest­ment and in­te­gra­tion costs and in­come in con­nec­tion with the San­itec ac­qui­si­tion

Free cashflow
(in CHF)


563.9 million
16.5% above prior year
Ad­justed op­er­at­ing cash­flow mar­gin
(EBITDA mar­gin)

28.3%

1.6 per­cent­age higher than prior year

Payout ratio

63.4%
of ad­justed net sales
Ad­justed earn­ings per share
(in CHF)

15.85

19.8% above prior year

R&D expenditures
(in CHF)


72.3 million
+8.9 mil­lion ver­sus prior year
In­vest­ments in prop­erty, plant and equip­ment and in­tan­gi­ble as­sets
(in CHF)

139.1 mil­lion

-5.6% ver­sus prior year

Currency effects in net sales
(in CHF)


+18 million
Cur­rency ef­fects in EBIT
(in CHF)

-0.5 mil­lion